| 中文名称: | Benzamil Hydrochloride Hydrate | 中文别名: | Benzamil Hydrochloride Hydrate |
|---|---|---|---|
| 英文名称: | Benzamil Hydrochloride Hydrate | CAS: | 161804-20-2 |
| 产品分类: | 小分子化合物 | 纯度: | ≥98% |
| 产品编号 | 品牌 | 纯度 | 规格 | 库存 | 价格 |
|---|---|---|---|---|---|
| IB2910 | 索莱宝 | ≥98% | 10mg | 有现货 | 650.00 元 |
| IB2910 | 索莱宝 | ≥98% | 5mg | 有现货 | 490.00 元 |
| IB2910 | 索莱宝 | ≥98% | 50mg | 有现货 | 2,590.00 元 |
| IB2910 | 索莱宝 | ≥98% | 100mg | 有现货 | 4,590.00 元 |
| 标准名称: | 3,5-二氨基-N-[(E)-氨基(苄基氨基)亚甲基]-6-氯-2-吡嗪甲酰胺盐酸盐(1:1) | 英文名称: | Benzamil hydrochloride |
|---|---|---|---|
| CAS: | 161804-20-2 | 分子式: | C13H15Cl2N7O |
| 分子量: | 356.2105 | 颜色与性状: | |
| 密度: | 沸点: | ||
| 熔点: | 水溶性: |
| CAS | 161804-20-2 |
| 英文名称 | Benzamil Hydrochloride Hydrate |
| 别名 | Benzylamiloridehydrochloride |
| 分子式 | C13H14ClN7O·HCl·xH2O |
| 分子量 | 356.21 (as Anhydrous) |
| 规格 | 10mg ; 5mg ; 50mg ; 100mg |
| 溶解性 | Soluble in DMSO |
| 纯度 | ≥98% |
| 外观(性状) | Light yellow to yellow Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| 运输条件 | 冷藏运输 |
| MDL | MFCD00069219 |
| SMILES | O=C(C1=NC(Cl)=C(N)N=C1N)NC(NCC2=CC=CC=C2)=N.[H]Cl |
| InChIKey | ZNWMRWWNJBXNKJ-UHFFFAOYSA-N |
| 靶点 | Sodium Channel |
| 通路 | Membrane Transporter&Ion Channel |
| 背景说明 | Benzamil hydrochloride 是钠通道(ENaC)的特异性阻断剂。 |
| 生物活性 | Benzamil hydrochloride (Benzylamiloride hydrochloride), an Amiloride analogue, is a Na+/Ca2+ exchanger (NCX) inhibitor (IC50~100 nM). Benzamil hydrochloride also is a non-selective Deg/epithelial sodium channels (ENaC) blocker, and can potentiate myogenic vasoconstriction. Benzamil hydrochloride inhibits TRPP3-mediated Ca2+-activated currents, with an IC50 of 1.1 μM.[1-5] |
| In Vitro | Benzamil hydrochloride (Benzylamiloride hydrochloride) 抑制神经元和异源表达的小电导 Ca2+-激活的 K2+ 通道[4]。 |
| In Vivo | Benzamil hydrochloride (Benzylamiloride hydrochloride) (0.7 mg/kg/天;sc) 处理的中风倾向自发性高血压大鼠 (SHRSP) 在 SHRSP 大鼠中平均存活至 16.1 周龄[5]。 |
| 细胞实验 | Individual CCD segments are dissected from rabbit and mouse kidney.The measurements of [Na+]i are used as a reflection of Na+ transport across the apical membrane. EnaC-specific activity is assessed by applying 10?6 M of the ENaC blocker Benzamil hydrochloride, a concentration that does not affect Na+:H+ exchange. Experiments are performed in the presence/absence of luminal Benzamil hydrochloride or the Na:H exchanger blocker HOE694 administers with/without the AT1 receptor blocker candesartan. Final DMSO concentrations are below 0.1% [2]. |
| 动物实验 | For the acute intracerebroventricular injection in anesthetized rats. A guide cannula is inserted into the right lateral cerebral ventricle, and Benzamil hydrochloride (0.1 nmol/kg, n=6; 1 nmol/kg, n=6; 10 nmol/kg,n=7) or vehicle (n=6) is injected into the right lateral ventricle through a cannula connected to a microsyringe 15 min before the start of intracerebroventricular infusion of hypertonic NaCl. Each injection consists of a volume of 10 μL deliver manually over a period of 30 s. To investigate the effects of Benzamil hydrochloride on the pressor response induced by intracerebroventricular injection of the pressor agent other than hypertonic NaCl, endothelin-1, which has a potent pressor action in the brain of rats, is intracerebroventricularly injected (1 nmol/10 μL) 15 min after the intracerebroventricular preinjection of Benzamil hydrochloride (10 nmol/kg, n=6) or the vehicle (n=6), and mean arterial pressure, heart rate, and abdominal sympathetic nerve firings are recorded for 20 min. Catheters are implanted into both the femoral artery and vein of 12-wk-old male rats anesthetized with urethan. Both catheters are filled with heparinized saline (50 U/mL). Fifteen minutes before the start of intracerebroventricular infusion of hypertonic NaCl, Benzamil hydrochloride (10 nmol/kg, n=6) or vehicle (10 μL, n=6) is injected into a tube connects to the femoral venous catheter by directly inserting the microsyringe, and 0.1 ml of isotonic saline solution is injected through the catheter to deliver the contents into the venous circulation[1]. |
| 数据来源文献 | [1]. Fischer KG, et al. Characterization of a Na(+)-Ca(2+) exchanger in podocytes. Nephrol Dial Transplant. 2002 Oct;17(10):1742-50. [2]. Wang X, et al. Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol. 2008 Jul;295(1):F272-82. [3]. Dai XQ, et al. Inhibition of TRPP3 channel by amiloride and analogs. Mol Pharmacol. 2007 Dec;72(6):1576-85. [4]. Casta?eda MS, et al. Benzamil inhibits neuronal and heterologously expressed small conductance Ca2+-activated K+channels. Neuropharmacology. 2019 Nov 1;158:107738. [5]. Teiwes J, et al. Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. Am J Hypertens. 2007 Jan;20(1):109-17. |
| 单位 | 瓶 |
公司拥有一批专业的研发人员,我们专注于生物产品的不断完善和创新。产品覆盖面广,品质可靠。先后开发了涵盖分子生物学、细胞生物学、免疫学、生物医学等领域的多种试剂及试剂盒。同时,索莱宝公司提供各种常规生化试剂,库存常备产品多达10000多种,可随时为广大科研工作者提供各类专业试剂。在质量方面,索莱宝谨记公司信念:质量高于一切。所有研发的产品都设有严谨的生产流程,科学的质量检测方法和成熟的质量检测程序,我们恪守对每一位用户的承诺:用专业的态度做专业的品牌。同时,公司组建了一支专业的技术服务队伍,能够为科研工作者提供专业的技术服务。每一位购买索莱宝产品的用户都能够得到专业的咨询和完善的售后服务。
索莱宝公司坚持与国际接轨,注重和国际先进企业的合作与交流,并提供产品代理、市场咨询等多项服务。公司将一如既往与世界更多知名品牌合作,不断为广大生物科研工作者提供更优质的产品和服务。公司理念:“为科研服务,为生命尽责”。一个人能够走多远,取决于与谁同行。索莱宝公司期待与各同行精诚合作。
索莱宝诚招生物试剂研发人员,期待与广大同行精诚合作,为广大科研工作者提供优质的产品,高效的物流以及专业的售后服务。索莱宝感谢所有朋友的支持与帮助,您的支持是我们前进的动力和保障。让我们携手同行,共同创造美好的明天。
| 企业认证: | 已认证 | 企业性质: | 生产研发 |
|---|---|---|---|
| 主营产品: | 3-羟基苯乙酸 ; 1-氨基-1-环己基甲酸 ; 阿奇霉素 ; 甲磺酸达氟沙星 ; CY7-N-羟基琥珀酰胺酯 三乙胺盐 ; | 供货范围: | 试剂 |
| 产品目录: | 119719 | 品牌: | 索莱宝 |
| 纯度 | 品牌 | 规格 | 发货地 |
|---|---|---|---|
| 98.00% | 索莱宝 | 5g / 10g / 25g / 100g | 北京 |